{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:31:02Z","timestamp":1783470662763,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00482-022-00655-9","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T19:02:55Z","timestamp":1657738975000},"page":"293-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unerw\u00fcnschte Wirkungen von Opioiden, Antidepressiva und Antikonvulsiva auf Sexualhormone","Adverse effects of opioids, antidepressants and anticonvulsants on sex hormones"],"prefix":"10.1007","volume":"36","author":[{"given":"Stefan","family":"Wirz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Kieselbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"655_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00940-021-3226-y","volume":"37","author":"S Wirz","year":"2021","unstructured":"Wirz\u00a0S (2021) Worauf bei einer Dauertherapie zu achten ist \u2013 Antiandrogene Wirkungen von Opioiden. Schmerzmedizin 37:26\u201334","journal-title":"Schmerzmedizin"},{"issue":"Suppl 1","key":"655_CR2","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/pme.12926","volume":"16","author":"JA Gudin","year":"2015","unstructured":"Gudin\u00a0JA, Laitman\u00a0A, Nalamachu\u00a0S (2015) Opioid related Endocrinopathy. Pain Med 16(Suppl 1):S9\u2013S15","journal-title":"Pain Med"},{"key":"655_CR3","first-page":"ES145","volume":"15","author":"HS Smith","year":"2012","unstructured":"Smith\u00a0HS, Elliott\u00a0JA (2012) Opioid-induced androgen deficiency (OPIAD). Pain Physician 15:ES145\u2013ES156","journal-title":"Pain Physician"},{"key":"655_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/er.2009-0009","volume":"31","author":"C Vuong","year":"2010","unstructured":"Vuong\u00a0C, Van Uum\u00a0SH, O\u2019Dell\u00a0LE, Lutfy\u00a0K, Friedman\u00a0TC (2010) The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31:98\u2013132","journal-title":"Endocr Rev"},{"key":"655_CR5","volume-title":"Opioid-induced endocrinopathy","author":"WACT Medina II","year":"2021","unstructured":"Medina\u00a0WACT II (2021) Opioid-induced endocrinopathy. StatPearls, Treasure Island (FL)"},{"key":"655_CR6","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/EJE-18-0270","volume":"179","author":"A Fountas","year":"2018","unstructured":"Fountas\u00a0A, Chai\u00a0ST, Kourkouti\u00a0C, Karavitaki\u00a0N (2018) Mechanisms of endocrinology: endocrinology of opioids. Eur J Endocrinol 179:R183\u2013R196","journal-title":"Eur J Endocrinol"},{"key":"655_CR7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s40618-018-0964-3","volume":"41","author":"F Coluzzi","year":"2018","unstructured":"Coluzzi\u00a0F, Billeci\u00a0D, Maggi\u00a0M, Corona\u00a0G (2018) Testosterone deficiency in non-cancer opioid-treated patients. J\u00a0Endocrinol Invest 41:1377\u20131388","journal-title":"J Endocrinol Invest"},{"key":"655_CR8","doi-asserted-by":"publisher","first-page":"T101","DOI":"10.1530\/JOE-15-0213","volume":"226","author":"DR Grattan","year":"2015","unstructured":"Grattan\u00a0DR (2015) 60 years of neuroendocrinology: the hypothalamo-prolactin axis. J\u00a0Endocrinol 226:T101\u2013T122","journal-title":"J Endocrinol"},{"key":"655_CR9","first-page":"e10813","volume":"12","author":"S Marudhai","year":"2020","unstructured":"Marudhai\u00a0S, Patel\u00a0M, Valaiyaduppu Subas\u00a0S, Ghani\u00a0MR, Busa\u00a0V, Dardeir\u00a0A, Cancarevic\u00a0I (2020) Long-term opioids linked to hypogonadism and the role of testosterone supplementation therapy. Cureus 12:e10813","journal-title":"Cureus"},{"key":"655_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jpain.2006.04.011","volume":"7","author":"HW Daniell","year":"2006","unstructured":"Daniell\u00a0HW (2006) DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. J\u00a0Pain 7:901\u2013907","journal-title":"J Pain"},{"key":"655_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz022","author":"F de Vries","year":"2020","unstructured":"de Vries\u00a0F, Bruin\u00a0M, Lobatto\u00a0DJ, Dekkers\u00a0OM, Schoones\u00a0JW, van Furth\u00a0WR, Pereira\u00a0AM, Karavitaki\u00a0N, Biermasz\u00a0NR, Zamanipoor Najafabadi\u00a0AH (2020) Opioids and their endocrine effects: a\u00a0systematic review and meta-analysis. J\u00a0Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz022","journal-title":"Clin Endocrinol Metab"},{"key":"655_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","volume":"26","author":"A Rhodin","year":"2010","unstructured":"Rhodin\u00a0A, Stridsberg\u00a0M, Gordh\u00a0T (2010) Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 26:374\u2013380","journal-title":"Clin J Pain"},{"key":"655_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","volume":"9","author":"HW Daniell","year":"2008","unstructured":"Daniell\u00a0HW (2008) Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J\u00a0Pain 9:28\u201336","journal-title":"J Pain"},{"key":"655_CR14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0885-3924(03)00331-2","volume":"26","author":"A Rajagopal","year":"2003","unstructured":"Rajagopal\u00a0A, Vassilopoulou-Sellin\u00a0R, Palmer\u00a0JL, Kaur\u00a0G, Bruera\u00a0E (2003) Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J\u00a0Pain Symptom Manage 26:1055\u20131061","journal-title":"J Pain Symptom Manage"},{"key":"655_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/AJP.0b013e31827c7b5d","volume":"29","author":"AL Rubinstein","year":"2013","unstructured":"Rubinstein\u00a0AL, Carpenter\u00a0DM, Minkoff\u00a0JR (2013) Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids. Clin J Pain 29:840\u2013845","journal-title":"Clin J Pain"},{"key":"655_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.31486\/toj.20.0103","volume":"21","author":"Y Eshraghi","year":"2021","unstructured":"Eshraghi\u00a0Y, Hanks\u00a0N, Rooney\u00a0S, Ata\u00a0FMY, Velasco\u00a0C, Guirguis\u00a0M, Uwaifo\u00a0G (2021) Establishing a dose-response relationship between opioid use and hypogonadism: a retrospective case-control study. Ochsner\u00a0J 21:249\u2013253","journal-title":"Ochsner J"},{"key":"655_CR17","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","volume":"85","author":"R Abs","year":"2000","unstructured":"Abs\u00a0R, Verhelst\u00a0J, Maeyaert\u00a0J, Van Buyten\u00a0JP, Opsomer\u00a0F, Adriaensen\u00a0H, Verlooy\u00a0J, Van Havenbergh\u00a0T, Smet\u00a0M, Van Acker\u00a0K (2000) Endocrine consequences of long-term intrathecal administration of opioids. J\u00a0Clin Endocrinol Metab 85:2215\u20132222","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002856","author":"RV Duarte","year":"2013","unstructured":"Duarte\u00a0RV, Raphael\u00a0JH, Southall\u00a0JL, Labib\u00a0MH, Whallett\u00a0AJ, Ashford\u00a0RL (2013) Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2013-002856","journal-title":"BMJ Open"},{"key":"655_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ijir.2014.18","volume":"26","author":"A Yee","year":"2014","unstructured":"Yee\u00a0A, Loh\u00a0HS, Hashim\u00a0HHM, Ng\u00a0CG (2014) Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study. Int J Impot Res 26:161\u2013166","journal-title":"Int J Impot Res"},{"key":"655_CR20","first-page":"637","volume":"18","author":"AL Rubinstein","year":"2017","unstructured":"Rubinstein\u00a0AL, Carpenter\u00a0DM (2017) Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis. Pain Med 18:637\u2013644","journal-title":"Pain Med"},{"key":"655_CR21","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1097\/PR9.0000000000000840","volume":"5","author":"F Petzke","year":"2020","unstructured":"Petzke\u00a0F, Bock\u00a0F, Huppe\u00a0M, Nothacker\u00a0M, Norda\u00a0H, Radbruch\u00a0L, Schiltenwolf\u00a0M, Schuler\u00a0M, Tolle\u00a0T, Viniol\u00a0A, Hauser\u00a0W (2020) Long-term opioid therapy for chronic noncancer pain: second update of the German guidelines. Pain Rep 5:e840","journal-title":"Pain Rep"},{"key":"655_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/papr.12361","volume":"16","author":"R Baron","year":"2016","unstructured":"Baron\u00a0R, Jansen\u00a0JP, Binder\u00a0A, Pombo-Suarez\u00a0M, Kennes\u00a0L, Muller\u00a0M, Falke\u00a0D, Steigerwald\u00a0I (2016) Tolerability, safety, and quality of life with tapentadol prolonged release (PR) compared with oxycodone\/naloxone PR in patients with severe chronic low back pain with a neuropathic component: a randomized, controlled, open-label, phase 3b\/4 trial. Pain Pract 16:600\u2013619","journal-title":"Pain Pract"},{"key":"655_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5055\/jom.2015.0270","volume":"11","author":"G Eichenbaum","year":"2015","unstructured":"Eichenbaum\u00a0G, Gohler\u00a0K, Etropolski\u00a0M, Steigerwald\u00a0I, Pergolizzi\u00a0J, Kim\u00a0M, Vorsanger\u00a0G (2015) Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency. J\u00a0Opioid Manag 11:211\u2013227","journal-title":"J Opioid Manag"},{"issue":"Suppl 1","key":"655_CR24","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/j.psyneuen.2009.05.013","volume":"34","author":"AM Aloisi","year":"2009","unstructured":"Aloisi\u00a0AM, Aurilio\u00a0C, Bachiocco\u00a0V, Biasi\u00a0G, Fiorenzani\u00a0P, Pace\u00a0MC, Paci\u00a0V, Pari\u00a0G, Passavanti\u00a0G, Ravaioli\u00a0L, Sindaco\u00a0G, Vellucci\u00a0R, Ceccarelli\u00a0I (2009) Endocrine consequences of opioid therapy. Psychoneuroendocrinology 34(Suppl 1):S162\u2013S168","journal-title":"Psychoneuroendocrinology"},{"key":"655_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1210\/jc.2004-0929","volume":"90","author":"N Bliesener","year":"2005","unstructured":"Bliesener\u00a0N, Albrecht\u00a0S, Schwager\u00a0A, Weckbecker\u00a0K, Lichtermann\u00a0D, Klingmuller\u00a0D (2005) Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J\u00a0Clin Endocrinol Metab 90:203\u2013206","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/HRP.0000000000000198","volume":"26","author":"WW IsHak","year":"2018","unstructured":"IsHak\u00a0WW, Wen\u00a0RY, Naghdechi\u00a0L, Vanle\u00a0B, Dang\u00a0J, Knosp\u00a0M, Dascal\u00a0J, Marcia\u00a0L, Gohar\u00a0Y, Eskander\u00a0L, Yadegar\u00a0J, Hanna\u00a0S, Sadek\u00a0A, Aguilar-Hernandez\u00a0L, Danovitch\u00a0I, Louy\u00a0C (2018) Pain and depression: a systematic review. Harv Rev Psychiatry 26:352\u2013363","journal-title":"Harv Rev Psychiatry"},{"key":"655_CR27","doi-asserted-by":"publisher","first-page":"643609","DOI":"10.3389\/fpsyt.2021.643609","volume":"12","author":"WH Roughan","year":"2021","unstructured":"Roughan\u00a0WH, Campos\u00a0AI, Garcia-Marin\u00a0LM, Cuellar-Partida\u00a0G, Lupton\u00a0MK, Hickie\u00a0IB, Medland\u00a0SE, Wray\u00a0NR, Byrne\u00a0EM, Ngo\u00a0TT, Martin\u00a0NG, Renteria\u00a0ME (2021) Comorbid chronic pain and depression: shared risk factors and differential antidepressant effectiveness. Front Psychiatry 12:643609","journal-title":"Front Psychiatry"},{"key":"655_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11916-019-0803-z","volume":"23","author":"I Urits","year":"2019","unstructured":"Urits\u00a0I, Peck\u00a0J, Orhurhu\u00a0MS, Wolf\u00a0J, Patel\u00a0R, Orhurhu\u00a0V, Kaye\u00a0AD, Viswanath\u00a0O (2019) Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review. Curr Pain Headache Rep 23:66","journal-title":"Curr Pain Headache Rep"},{"key":"655_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/00048670903107575","volume":"43","author":"I Schweitzer","year":"2009","unstructured":"Schweitzer\u00a0I, Maguire\u00a0K, Ng\u00a0C (2009) Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry 43:795\u2013808","journal-title":"Aust N Z J Psychiatry"},{"key":"655_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/clpt.2010.70","volume":"89","author":"A Serretti","year":"2011","unstructured":"Serretti\u00a0A, Chiesa\u00a0A (2011) Sexual side effects of pharmacological treatment of psychiatric diseases. Clin Pharmacol Ther 89:142\u2013147","journal-title":"Clin Pharmacol Ther"},{"key":"655_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/00926239708403923","volume":"23","author":"AL Montejo-Gonzalez","year":"1997","unstructured":"Montejo-Gonzalez\u00a0AL, Llorca\u00a0G, Izquierdo\u00a0JA, Ledesma\u00a0A, Bousono\u00a0M, Calcedo\u00a0A, Carrasco\u00a0JL, Ciudad\u00a0J, De la Daniel\u00a0E, Gandara\u00a0J, Derecho\u00a0J, Franco\u00a0M, Gomez\u00a0MJ, Macias\u00a0JA, Martin\u00a0T, Perez\u00a0V, Sanchez\u00a0JM, Sanchez\u00a0S, Vicens\u00a0E (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J\u00a0Sex Marital Ther 23:176\u2013194","journal-title":"J Sex Marital Ther"},{"key":"655_CR32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/01.jcp.0000239790.83707.ab","volume":"26","author":"ME Thase","year":"2006","unstructured":"Thase\u00a0ME, Clayton\u00a0AH, Haight\u00a0BR, Thompson\u00a0AH, Modell\u00a0JG, Johnston\u00a0JA (2006) A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J\u00a0Clin Psychopharmacol 26:482\u2013488","journal-title":"J Clin Psychopharmacol"},{"key":"655_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/17453674.2018.1543842","volume":"90","author":"SB Bruun","year":"2019","unstructured":"Bruun\u00a0SB, Petersen\u00a0I, Kristensen\u00a0NR, Cronin-Fenton\u00a0D, Pedersen\u00a0AB (2019) Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study. Acta Orthop 90:33\u201339","journal-title":"Acta Orthop"},{"key":"655_CR34","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/jsm.12458","volume":"11","author":"M Bozkurt","year":"2014","unstructured":"Bozkurt\u00a0M, Gocmez\u00a0C, Soylemez\u00a0H, Daggulli\u00a0M, Em\u00a0S, Yildiz\u00a0M, Atar\u00a0M, Bozkurt\u00a0Y, Ozbey\u00a0I (2014) Association between neuropathic pain, pregabalin treatment, and erectile dysfunction. J\u00a0Sex Med 11:1816\u20131822","journal-title":"J Sex Med"},{"key":"655_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1684\/epd.2013.0592","volume":"15","author":"RS Calabro","year":"2013","unstructured":"Calabro\u00a0RS, De Luca\u00a0R, Pollicino\u00a0P, Bramanti\u00a0P (2013) Anorgasmia during pregabalin add-on therapy for partial seizures. Epileptic Disord 15:358\u2013361","journal-title":"Epileptic Disord"},{"key":"655_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/WNF.0000000000000286","volume":"41","author":"SA Hamed","year":"2018","unstructured":"Hamed\u00a0SA (2018) Sexual dysfunctions induced by pregabalin. Clin Neuropharmacol 41:116\u2013122","journal-title":"Clin Neuropharmacol"},{"key":"655_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","volume":"28","author":"S Svalheim","year":"2015","unstructured":"Svalheim\u00a0S, Sveberg\u00a0L, Mochol\u00a0M, Tauboll\u00a0E (2015) Interactions between antiepileptic drugs and hormones. Seizure 28:12\u201317","journal-title":"Seizure"},{"key":"655_CR38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1528-1157.1988.tb03747.x","volume":"29","author":"GJ Macphee","year":"1988","unstructured":"Macphee\u00a0GJ, Larkin\u00a0JG, Butler\u00a0E, Beastall\u00a0GH, Brodie\u00a0MJ (1988) Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 29:468\u2013475","journal-title":"Epilepsia"},{"key":"655_CR39","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1528-1167.2006.00506.x","volume":"47","author":"E Lofgren","year":"2006","unstructured":"Lofgren\u00a0E, Tapanainen\u00a0JS, Koivunen\u00a0R, Pakarinen\u00a0A, Isojarvi\u00a0JI (2006) Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. Epilepsia 47:1441\u20131446","journal-title":"Epilepsia"},{"key":"655_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1743-6109.2012.02951.x","volume":"10","author":"RM Reis","year":"2013","unstructured":"Reis\u00a0RM, de Angelo\u00a0AG, Sakamoto\u00a0AC, Ferriani\u00a0RA, Lara\u00a0LA (2013) Altered sexual and reproductive functions in epileptic men taking carbamazepine. J\u00a0Sex Med 10:493\u2013499","journal-title":"J Sex Med"},{"key":"655_CR41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1528-1157.1990.tb05500.x","volume":"31","author":"JI Isojarvi","year":"1990","unstructured":"Isojarvi\u00a0JI (1990) Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy. Epilepsia 31:438\u2013445","journal-title":"Epilepsia"},{"key":"655_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1210\/jcem-63-1-243","volume":"63","author":"LA Levesque","year":"1986","unstructured":"Levesque\u00a0LA, Herzog\u00a0AG, Seibel\u00a0MM (1986) The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J\u00a0Clin Endocrinol Metab 63:243\u2013245","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR43","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000178988.78039.40","volume":"65","author":"AG Herzog","year":"2005","unstructured":"Herzog\u00a0AG, Drislane\u00a0FW, Schomer\u00a0DL, Pennell\u00a0PB, Bromfield\u00a0EB, Dworetzky\u00a0BA, Farina\u00a0EL, Frye\u00a0CA (2005) Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 65:1016\u20131020","journal-title":"Neurology"},{"issue":"Suppl 6","key":"655_CR44","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1111\/j.1528-1157.1991.tb05890.x","volume":"32","author":"AG Herzog","year":"1991","unstructured":"Herzog\u00a0AG (1991) Reproductive endocrine considerations and hormonal therapy for men with epilepsy. Epilepsia 32(Suppl 6):S34\u2013S37","journal-title":"Epilepsia"},{"key":"655_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/WNL.57.3.440","volume":"57","author":"J Rattya","year":"2001","unstructured":"Rattya\u00a0J, Pakarinen\u00a0AJ, Knip\u00a0M, Repo-Outakoski\u00a0M, Myllyla\u00a0VV, Isojarvi\u00a0JI (2001) Early hormonal changes during valproate or carbamazepine treatment: a 3\u2011month study. Neurology 57:440\u2013444","journal-title":"Neurology"},{"key":"655_CR46","first-page":"6624101","volume":"2021","author":"Y Guo","year":"2021","unstructured":"Guo\u00a0Y, Chen\u00a0L, Wu\u00a0D, Yu\u00a0L, Sun\u00a0H, Zhu\u00a0Q (2021) A comparative study of the effects of valproate and oxcarbazepine on sexual function, sperm quality, and sex hormones in males with epilepsy. Biomed Res Int 2021:6624101","journal-title":"Biomed Res Int"},{"key":"655_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1528-1157.1992.tb02298.x","volume":"33","author":"SS Chen","year":"1992","unstructured":"Chen\u00a0SS, Shen\u00a0MR, Chen\u00a0TJ, Lai\u00a0SL (1992) Effects of antiepileptic drugs on sperm motility of normal controls and epileptic patients with long-term therapy. Epilepsia 33:149\u2013153","journal-title":"Epilepsia"},{"key":"655_CR48","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/humrep\/del194","volume":"21","author":"M Artama","year":"2006","unstructured":"Artama\u00a0M, Isojarvi\u00a0JI, Auvinen\u00a0A (2006) Antiepileptic drug use and birth rate in patients with epilepsy\u2014a population-based cohort study in Finland. Hum Reprod 21:2290\u20132295","journal-title":"Hum Reprod"},{"key":"655_CR49","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman\u00a0SM, Metter\u00a0EJ, Tobin\u00a0JD, Pearson\u00a0J, Blackman\u00a0MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J\u00a0Clin Endocrinol Metab 86:724\u2013731","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR50","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/AJP.0b013e3181850df6","volume":"25","author":"N Katz","year":"2009","unstructured":"Katz\u00a0N, Mazer\u00a0NA (2009) The impact of opioids on the endocrine system. Clin J Pain 25:170\u2013175","journal-title":"Clin J Pain"},{"key":"655_CR51","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa499","author":"T Li","year":"2020","unstructured":"Li\u00a0T, Cunningham\u00a0JL, Gilliam\u00a0WP, Loukianova\u00a0L, Donegan\u00a0DM, Bancos\u00a0I (2020) Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids. J\u00a0Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa499","journal-title":"Clin Endocrinol Metab"},{"key":"655_CR52","first-page":"653","volume":"117","author":"P Briken","year":"2020","unstructured":"Briken\u00a0P, Matthiesen\u00a0S, Pietras\u00a0L, Wiessner\u00a0C, Klein\u00a0V, Reed\u00a0GM, Dekker\u00a0A (2020) Estimating the prevalence of sexual dysfunction using the new ICD-11 guidelines. Dtsch Arztebl Int 117:653\u2013658","journal-title":"Dtsch Arztebl Int"},{"issue":"Suppl 6","key":"655_CR53","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00004850-199807006-00001","volume":"13","author":"J Angst","year":"1998","unstructured":"Angst\u00a0J (1998) Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 13(Suppl 6):S1\u2013S4","journal-title":"Int Clin Psychopharmacol"},{"key":"655_CR54","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1600-0447.2006.00890.x","volume":"114","author":"U Werneke","year":"2006","unstructured":"Werneke\u00a0U, Northey\u00a0S, Bhugra\u00a0D (2006) Antidepressants and sexual dysfunction. Acta Psychiatr Scand 114:384\u2013397","journal-title":"Acta Psychiatr Scand"},{"key":"655_CR55","doi-asserted-by":"publisher","first-page":"575","DOI":"10.7150\/ijms.52201","volume":"18","author":"FF Ramli","year":"2021","unstructured":"Ramli\u00a0FF, Syed Hashim\u00a0SA, Mohd Effendy\u00a0N (2021) Factors associated with low bone density in opioid substitution therapy patients: a systematic review. Int J Med Sci 18:575\u2013581","journal-title":"Int J Med Sci"},{"key":"655_CR56","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/papr.12731","volume":"19","author":"U Hochberg","year":"2019","unstructured":"Hochberg\u00a0U, Ojeda\u00a0A, Brill\u00a0S, Perez\u00a0J (2019) An internet-based survey to assess clinicians\u2019 knowledge and attitudes towards opioid-induced hypogonadism. Pain Pract 19:176\u2013182","journal-title":"Pain Pract"},{"key":"655_CR57","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.amjmed.2012.12.001","volume":"126","author":"MJ Brennan","year":"2013","unstructured":"Brennan\u00a0MJ (2013) The effect of opioid therapy on endocrine function. Am J Med 126:S12\u2013S18","journal-title":"Am J Med"},{"key":"655_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7525-1-15","volume":"1","author":"LA Heinemann","year":"2003","unstructured":"Heinemann\u00a0LA, Saad\u00a0F, Zimmermann\u00a0T, Novak\u00a0A, Myon\u00a0E, Badia\u00a0X, Potthoff\u00a0P, T\u2019Sjoen\u00a0G, Pollanen\u00a0P, Goncharow\u00a0NP, Kim\u00a0S, Giroudet\u00a0C (2003) The Aging Males\u2019 Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes 1:15","journal-title":"Health Qual Life Outcomes"},{"key":"655_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.eururo.2004.01.009","volume":"46","author":"C Moore","year":"2004","unstructured":"Moore\u00a0C, Huebler\u00a0D, Zimmermann\u00a0T, Heinemann\u00a0LA, Saad\u00a0F, Thai\u00a0DM (2004) The Aging Males\u2019 Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 46:80\u201387","journal-title":"Eur Urol"},{"key":"655_CR60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00108-020-00796-y","volume":"61","author":"M Zitzmann","year":"2020","unstructured":"Zitzmann\u00a0M (2020) Testosterontherapie im Alter bei Hypogonadismus und Komorbidit\u00e4ten. Internist 61:549\u2013557","journal-title":"Internist"},{"key":"655_CR61","first-page":"561","volume":"86","author":"KK Miller","year":"2001","unstructured":"Miller\u00a0KK, Sesmilo\u00a0G, Schiller\u00a0A, Schoenfeld\u00a0D, Burton\u00a0S, Klibanski\u00a0A (2001) Androgen deficiency in women with hypopituitarism. J\u00a0Clin Endocrinol Metab 86:561\u2013567","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR62","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1210\/jc.2009-2354","volume":"95","author":"S Bhasin","year":"2010","unstructured":"Bhasin\u00a0S, Cunningham\u00a0GR, Hayes\u00a0FJ, Matsumoto\u00a0AM, Snyder\u00a0PJ, Swerdloff\u00a0RS, Montori\u00a0VM, Task Force ES (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J\u00a0Clin Endocrinol Metab 95:2536\u20132559","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR63","first-page":"ES111","volume":"15","author":"C De Maddalena","year":"2012","unstructured":"De Maddalena\u00a0C, Bellini\u00a0M, Berra\u00a0M, Meriggiola\u00a0MC, Aloisi\u00a0AM (2012) Opioid-induced hypogonadism: why and how to treat it. Pain Physician 15:ES111\u2013ES118","journal-title":"Pain Physician"},{"key":"655_CR64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/13697131003675922","volume":"13","author":"N Panay","year":"2010","unstructured":"Panay\u00a0N, Al-Azzawi\u00a0F, Bouchard\u00a0C, Davis\u00a0SR, Eden\u00a0J, Lodhi\u00a0I, Rees\u00a0M, Rodenberg\u00a0CA, Rymer\u00a0J, Schwenkhagen\u00a0A, Sturdee\u00a0DW (2010) Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 13:121\u2013131","journal-title":"Climacteric"},{"key":"655_CR65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.mayocpiqo.2019.06.007","volume":"3","author":"J Baillargeon","year":"2019","unstructured":"Baillargeon\u00a0J, Raji\u00a0MA, Urban\u00a0RJ, Lopez\u00a0DS, Williams\u00a0SB, Westra\u00a0JR, Kuo\u00a0YF (2019) Opioid-induced hypogonadism in the United States. Mayo Clin Proc Innov Qual Outcomes 3:276\u2013284","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"655_CR66","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1526-4637.2003.03041.x","volume":"4","author":"A Rajagopal","year":"2003","unstructured":"Rajagopal\u00a0A, Bruera\u00a0ED (2003) Improvement in sexual function after reduction of chronic high-dose opioid medication in a cancer survivor. Pain Med 4:379\u2013383","journal-title":"Pain Med"},{"key":"655_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101640","author":"AL Montejo","year":"2019","unstructured":"Montejo\u00a0AL, Prieto\u00a0N, de Alarcon\u00a0R, Casado-Espada\u00a0N, de la Iglesia\u00a0J, Montejo\u00a0L (2019) Management strategies for antidepressant-related sexual dysfunction: a\u00a0clinical approach. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm8101640","journal-title":"Clin Med"},{"key":"655_CR68","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pbb.2013.11.003","volume":"121","author":"RT Segraves","year":"2014","unstructured":"Segraves\u00a0RT, Balon\u00a0R (2014) Antidepressant-induced sexual dysfunction in men. Pharmacol Biochem Behav 121:132\u2013137","journal-title":"Pharmacol Biochem Behav"},{"key":"655_CR69","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/1557988317734519","volume":"12","author":"LW Chen","year":"2018","unstructured":"Chen\u00a0LW, Chen\u00a0MY, Lian\u00a0ZP, Lin\u00a0HS, Chien\u00a0CC, Yin\u00a0HL, Chu\u00a0YH, Chen\u00a0KY (2018) Amitriptyline and sexual function: a systematic review updated for sexual health practice. Am J Mens Health 12:370\u2013379","journal-title":"Am J Mens Health"},{"key":"655_CR70","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/pm\/pny040","volume":"20","author":"M AminiLari","year":"2019","unstructured":"AminiLari\u00a0M, Manjoo\u00a0P, Craigie\u00a0S, Couban\u00a0R, Wang\u00a0L, Busse\u00a0JW (2019) Hormone replacement therapy and opioid tapering for opioid-induced hypogonadism among patients with chronic noncancer pain: a systematic review. Pain Med 20:301\u2013313","journal-title":"Pain Med"},{"key":"655_CR71","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/EJE-15-0262","volume":"174","author":"G Corona","year":"2016","unstructured":"Corona\u00a0G, Giagulli\u00a0VA, Maseroli\u00a0E, Vignozzi\u00a0L, Aversa\u00a0A, Zitzmann\u00a0M, Saad\u00a0F, Mannucci\u00a0E, Maggi\u00a0M (2016) Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol 174:R99\u2013R116","journal-title":"Eur J Endocrinol"},{"key":"655_CR72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1742-1241.2010.02355.x","volume":"64","author":"P Dandona","year":"2010","unstructured":"Dandona\u00a0P, Rosenberg\u00a0MT (2010) A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract 64:682\u2013696","journal-title":"Int J Clin Pract"},{"key":"655_CR73","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1210\/jc.2019-01603","volume":"104","author":"SR Davis","year":"2019","unstructured":"Davis\u00a0SR, Baber\u00a0R, Panay\u00a0N, Bitzer\u00a0J, Perez\u00a0SC, Islam\u00a0RM, Kaunitz\u00a0AM, Kingsberg\u00a0SA, Lambrinoudaki\u00a0I, Liu\u00a0J, Parish\u00a0SJ, Pinkerton\u00a0J, Rymer\u00a0J, Simon\u00a0JA, Vignozzi\u00a0L, Wierman\u00a0ME (2019) Global consensus position statement on the use of testosterone therapy for women. J\u00a0Clin Endocrinol Metab 104:4660\u20134666","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40618-014-0155-9","volume":"38","author":"AM Isidori","year":"2015","unstructured":"Isidori\u00a0AM, Balercia\u00a0G, Calogero\u00a0AE, Corona\u00a0G, Ferlin\u00a0A, Francavilla\u00a0S, Santi\u00a0D, Maggi\u00a0M (2015) Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J\u00a0Endocrinol Invest 38:103\u2013112","journal-title":"J Endocrinol Invest"},{"key":"655_CR75","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.jsxm.2016.10.009","volume":"13","author":"M Khera","year":"2016","unstructured":"Khera\u00a0M, Adaikan\u00a0G, Buvat\u00a0J, Carrier\u00a0S, El-Meliegy\u00a0A, Hatzimouratidis\u00a0K, McCullough\u00a0A, Morgentaler\u00a0A, Torres\u00a0LO, Salonia\u00a0A (2016) Diagnosis and treatment of testosterone deficiency: recommendations from the fourth international consultation for sexual medicine (ICSM 2015). J\u00a0Sex Med 13:1787\u20131804","journal-title":"J Sex Med"},{"key":"655_CR76","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1210\/jc.2014-2260","volume":"99","author":"ME Wierman","year":"2014","unstructured":"Wierman\u00a0ME, Arlt\u00a0W, Basson\u00a0R, Davis\u00a0SR, Miller\u00a0KK, Murad\u00a0MH, Rosner\u00a0W, Santoro\u00a0N (2014) Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab 99:3489\u20133510","journal-title":"J Clin Endocrinol Metab"},{"key":"655_CR77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5694\/mja16.00393","volume":"205","author":"BB Yeap","year":"2016","unstructured":"Yeap\u00a0BB, Grossmann\u00a0M, McLachlan\u00a0RI, Handelsman\u00a0DJ, Wittert\u00a0GA, Conway\u00a0AJ, Stuckey\u00a0BG, Lording\u00a0DW, Allan\u00a0CA, Zajac\u00a0JD, Burger\u00a0HG (2016) Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy. Med J Aust 205:173\u2013178","journal-title":"Med J Aust"},{"key":"655_CR78","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5694\/mja16.00448","volume":"205","author":"BB Yeap","year":"2016","unstructured":"Yeap\u00a0BB, Grossmann\u00a0M, McLachlan\u00a0RI, Handelsman\u00a0DJ, Wittert\u00a0GA, Conway\u00a0AJ, Stuckey\u00a0BG, Lording\u00a0DW, Allan\u00a0CA, Zajac\u00a0JD, Burger\u00a0HG (2016) Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Med J Aust 205:228\u2013231","journal-title":"Med J Aust"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-022-00655-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-022-00655-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-022-00655-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:05:30Z","timestamp":1658304330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-022-00655-9"}},"subtitle":["H\u00e4ufig unbeachtet, aber klinisch relevant","Often unnoticed but clinically relevant"],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s00482-022-00655-9","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>S.\u00a0Wirz<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Gr\u00fcnenthal, Mundipharma international, Dr.\u00a0Pfleger, Cannaflos\/Digitale Health Care, Kyowa Kirin, Besins, PACE.\u00a0\u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Mundipharma international, Dr.\u00a0Pfleger, Cannaflos\/Digitale Health Care, Kyowa Kirin, Stada, Hexal.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt GFO Kliniken Bonn; Betriebsst\u00e4tte Cura Bad Honnef; Sprecher Arbeitskreis Tumorschmerz der Deutschen Schmerzgesellschaft; Past Chair Cancer Special Interest Group, International Association for the Study of Pain (IASP) | Mitgliedschaften: Deutsche Schmerzgesellschaft; IASP; Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (DGAI); Berufsverband Deutscher An\u00e4sthesisten (BDA); Berufsverband der \u00c4rzte und Psychologischen Psychotherapeuten in der Schmerz- und Palliativmedizin in Deutschland (BVSD); Deutsche Gesellschaft f\u00fcr Schmerzmedizin (DGS); Sert\u00fcrner Gesellschaft. <b>M.\u00a0Schenk<\/b>: A.\u00a0Finanzielle Interessen: Seit 2017: Honorare f\u00fcr Vortr\u00e4ge, Firma Aristo: 2018, Firma Gr\u00fcnenthal: 2017\u20132020, 2022, Firma Hormosan: 2017, 2018, Firma Kyowa Kirin: 2018, Firma Novartis: 2018, Firma Indivior: 2017, 2018; Anmerkung: Es gibt keinen Interessenkonflikt mit meinem Thema \u201eAntiepileptika\u201c. Die Pr\u00e4parate der Fa. Pfizer sind inzwischen galenisch.\u00a0\u2013 Honorare f\u00fcr Teilnahmen an Advisory Boards: Firma Pfizer, Honorare f\u00fcr Teilnahmen an Advisory Boards, seit 2017 bis 2022.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt des Zentrums f\u00fcr Integrative Schmerzmedizin am Franziskus-Krankenhaus Berlin, angestellter Arzt im medizinischen Versorgungszentrum (MVZ) NOVOMED Praxis f\u00fcr Schmerzmedizin | Mitgliedschaften: Deutsche Schmerzgesellschaft, Berufsverband BVSD.<b> K.\u00a0Kieselbach<\/b>: A.\u00a0Finanzielle Interessen: K.\u00a0Kieselbach gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztliche Leiterin Interdisziplin\u00e4res Schmerzzentrum des Universit\u00e4tsklinikums Freiburg, Breisacher Str.\u00a0117, 79106 Freiburg; Fach\u00e4rztin f\u00fcr Neurochirurgie, spezielle Schmerztherapie und spezielle neurochirurgische Intensivmedizin | Mitgliedschaften: Deutsche Schmerzgesellschaft e.\u202fV., IASP, Deutsche Migr\u00e4ne- und Kopfschmerzgesellschaft (DMKG), Deutsche Gesellschaft f\u00fcr Neurochirurgie (DGNC), Deutsche Gesellschaft f\u00fcr Neurogastroenterologie und Motilit\u00e4t (DGNM), BVSD, Sert\u00fcrner Gesellschaft.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}